<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Suramin (United States: Available via CDC drug service investigational drug [IND] protocol only): Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Suramin (United States: Available via CDC drug service investigational drug [IND] protocol only): Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Suramin (United States: Available via CDC drug service investigational drug [IND] protocol only): Pediatric drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_general" data-topicid="10291" href="/d/html/10291.html" rel="external">see "Suramin (United States: Available via CDC drug service investigational drug [IND] protocol only): Drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="list_set htclist drugH1Div drugBrandNames" id="F1037123"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Antineoplastic Agent</span></li></ul></div>
<div class="block dop drugH1Div" id="F9776967"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="705ecbeb-6e76-4e0e-8a21-f6ef3399f3d5">African trypanosomiasis, first-stage disease, caused by <i>T. brucei rhodesiense</i></span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>African trypanosomiasis (sleeping sickness), </b>
<b>first-stage disease (without CNS involvement), </b>
<b>caused by </b>
<i>
<b>T. brucei rhodesiense</b></i>
<b>:</b>
<b>Note: </b>Suramin is only available through special distribution programs; refer to "Prescribing and Access Restrictions" for additional information.</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: IV: 2 mg/kg test dose once (maximum dose: 100 mg/dose); if test dose tolerated, then follow with treatment dose of 10 to 15 mg/kg/dose (maximum dose: 1,000 mg/dose) on days 1, 3, 7, 14, and 21 (CDC 2020). <b>Note:</b> Alternate doses and dosing schedules have been described (Faust 2004; WHO 1995), including higher doses of 20 mg/kg/dose (<i>Red Book </i>[AAP 2021]; Voogd 1993).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51220326"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">Children and Adolescents: Avoid use in severe renal impairment (WHO 1995).</p></div>
<div class="block dohp drugH1Div" id="F51220327"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">Children and Adolescents: Avoid use in severe hepatic impairment (WHO 1995).</p></div>
<div class="block doa drugH1Div" id="F224432"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="10291" href="/d/html/10291.html" rel="external">see "Suramin (United States: Available via CDC drug service investigational drug [IND] protocol only): Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="705ecbeb-6e76-4e0e-8a21-f6ef3399f3d5">African trypanosomiasis, first-stage disease, caused by <i>T. brucei rhodesiense</i></span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;display:inline">
<b>African trypanosomiasis, first-stage disease, caused by </b>
<i>
<b>T. brucei rhodesiense</b></i>
<b>:</b>
<b>IV:</b> Initial: 4 to 5 mg/kg test dose (day 0), followed by 20 mg/kg (maximum: 1 g/dose) on days 1, 3, 7, 14, and 21 (CDC 2022). <b>Note:</b> Not recommended for trypanosomiasis with CNS involvement (CDC 2021).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990861"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">Avoid use in severe renal impairment (WHO 1995).</p></div>
<div class="block doha drugH1Div" id="F50988140"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">Avoid use in severe hepatic impairment (WHO 1995).</p></div>
<div class="block adr drugH1Div" id="F224414"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: Collapse (Voogd 1993, WHO 1995), shock (Voogd 1993)</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Dermatitis (including exfoliative dermatitis) (WHO 1995, Wiedemar 2020), exfoliation of skin (especially superficial peeling of palms and scaling of skin of feet) (Voogd 1993), papular rash (Voogd 1993), pruritus (Voogd 1993), skin rash (CDC 2022), urticaria (Voogd 1993)</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Albuminuria (WHO 1995), increased thirst (WHO 1995)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Anorexia (WHO 1995), nausea (Babokhov 2013), severe diarrhea (WHO 1995), stomatitis (Voogd 1993, WHO 1995), vomiting (Voogd 1993)</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Prostration (WHO 1995), proteinuria (WHO 1995)</p>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Anemia (Wiedemar 2020), bone marrow depression (Wiedemar 2020), disorder of hemostatic components of blood (Voogd 1993), hemolytic anemia (Voogd 1993), immune thrombocytopenia (Vayne 2020)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Hypersensitivity reaction (including anaphylactic shock) (Babokhov 2013, CDC 2022, Wiedemar 2020)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Localized tenderness (palms and soles) (WHO 1995)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Fatigue (WHO 1995), hyperesthesia (cutaneous; including hands and feet) (Voogd 1993), malaise (WHO 1995), peripheral neuropathy (CDC 2022), polyneuropathy (Voogd 1993)</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic: Conjunctivitis (Voogd 1993), eyelid edema (Voogd 1993), photophobia (Voogd 1993)</p>
<p style="text-indent:-2em;margin-left:4em;">Renal: Nephrotoxicity (CDC 2022), polyuria (WHO 1995)</p>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Fever (WHO 1995)</p></div>
<div class="block coi drugH1Div" id="F224421"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to suramin or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F224412"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Hypersensitivity reaction: Use has been associated with immediate hypersensitivity reactions, including severe reactions leading to shock and loss of consciousness.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Renal toxicity: Use has been associated with proteinuria and renal toxicity.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Hepatic impairment: Avoid use in hepatic impairment.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Renal impairment: Avoid use in renal impairment.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F55869144"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Suramin is also active against <i>Onchocerca volvulus</i>; patients treated with suramin who have trypanosomiasis and onchocerciasis coinfection may experience severe reactions (due to dying parasites); consider alternate therapy or exclude onchocerciasis coinfection (Kappagoda 2011; <i>Red Book</i> [AAP 2021]).</p></div>
<div class="block foc drugH1Div" id="F224417"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">Injection, powder for reconstitution: 1 g [Limited by law to investigational use only]</p></div>
<div class="block geq drugH1Div" id="F224409"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block accres drugH1Div" id="F11234335"><span class="drugH1">Prescribing and Access Restrictions</span>
<p style="text-indent:0em;display:inline">Suramin is not commercially available in the US; it is available for the treatment of patients with African trypanosomiasis through the Centers for Disease Control (CDC) Drug Service to be used under an Investigational New Drug (IND) protocol. To obtain treatment advice and obtain suramin, contact the Division of Parasitic Diseases and Malaria (404-718-4745; <a class="__cf_email__" data-cfemail="9cecfdeefdeff5e8f9efdcfff8ffb2fbf3ea" href="/cdn-cgi/l/email-protection">[email protected]</a>), the CDC Drug Service (404-639-3670; <a class="__cf_email__" data-cfemail="e98d9b9c8e9a8c9b9f808a8ca98a8d8ac78e869f" href="/cdn-cgi/l/email-protection">[email protected]</a>), or for emergencies after business hours, on weekends, and on federal holidays, the CDC Emergency Operations Center (770-488-7100). Additional information from the CDC is available at <a href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Flaboratory%2Fdrugservice%2Fformulary.html&amp;token=8fUMx%2BfB4trlY8x%2FMo8Y9Ddj5kItZ1H7qlW%2Fe3GJptY28xGubTU0DXWzUi5nl8%2BCwNhzfAcY95p7Mq5fGdd6Fg%3D%3D&amp;TOPIC_ID=132034" target="_blank">https://www.cdc.gov/laboratory/drugservice/formulary.html</a>.</p></div>
<div class="block admp drugH1Div" id="F52613894"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Parenteral: IV: Administer by slow IV infusion (Voogd 1993; WHO 1995).</p></div>
<div class="block adm drugH1Div" id="F224418"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>IV:</b> Administer by slow IV infusion over several hours (CDC 2022; Voogd 1993; WHO 1995).</p></div>
<div class="block sts drugH1Div" id="F224429"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Vials of powder for reconstitution should be protected from light.</p></div>
<div class="block usep drugH1Div" id="F55869143"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Treatment of first-stage African trypanosomiasis (sleeping sickness), without involvement of the central nervous system, due to <i>Trypanosoma brucei rhodesiense</i>. <b>Note: </b>Suramin is only available through the CDC for patients meeting Investigational New Drug eligibility criteria; contact CDC for details.</p></div>
<div class="block cyt drugH1Div" id="F55777925"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F55777922"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block mopp drugH1Div" id="F55869160"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Monitor for hypersensitivity and hemodynamic stability, especially following test dose (CDC 2020). Also monitor for peripheral neuropathy. Monitor urine output (routinely during therapy); urinalysis, urine protein, CBC, LFTs, and renal function tests (baseline and weekly during therapy) (Sinha 1999; Voogd 1993; WHO 1995).</p></div>
<div class="block phk drugH1Div" id="F224420"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Not absorbed orally.</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: Does not penetrate the CNS.</p>
<p style="text-indent:-2em;margin-left:2em;">Protein binding: 99.7% (Babokhov 2013).</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life elimination: 44 to 54 days (Babokhov 2013).</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Detectable unchanged in the urine for 3 months (WHO 1995).</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  American Academy of Pediatrics (AAP). In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. <i>Red Book: 2021-2024 Report of the Committee on Infectious Diseases</i>. 32nd ed. American Academy of Pediatrics; 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23916333">
<a name="23916333"></a>Babokhov P, Sanyaolu AO, Oyibo WA, Fagbenro-Beyioku AF, Iriemenam NC. A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis. <i>Pathog Glob Health</i>. 2013;107(5):242-252. doi:10.1179/2047773213Y.0000000105<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/suramin-united-states-available-via-cdc-drug-service-investigational-drug-ind-protocol-only-pediatric-drug-information/abstract-text/23916333/pubmed" id="23916333" target="_blank">23916333</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.1">
<a name="CDC.1"></a>Centers for Disease Control and Prevention (CDC). Infectious Diseases Laboratories. Our formulary. <a href="https://www.cdc.gov/laboratory/drugservice/formulary.html" target="_blank">https://www.cdc.gov/laboratory/drugservice/formulary.html</a>. Updated May 2018. Accessed May 10, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.2">
<a name="CDC.2"></a>Centers for Disease Control and Prevention (CDC). Infectious Diseases Laboratories. Our formulary. <a href="https://www.cdc.gov/laboratory/drugservice/formulary.html" target="_blank">https://www.cdc.gov/laboratory/drugservice/formulary.html</a>. Updated December 29, 2021. Accessed March 16, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.3">
<a name="CDC.3"></a>Centers for Disease Control and Prevention (CDC). Parasites - African trypanosomiasis (also known as sleeping sickness). Resources for health professionals. <a href="https://www.cdc.gov/parasites/sleepingsickness/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/sleepingsickness/health_professionals/index.html</a>. Last reviewed August 12, 2020. Accessed June 14, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.4">
<a name="CDC.4"></a>Centers for Disease Control and Prevention (CDC). Parasites - African trypanosomiasis (also known as sleeping sickness). Resources for health professionals. <a href="https://www.cdc.gov/parasites/sleepingsickness/health_professionals/index.html" target="_blank">https://www.cdc.gov/parasites/sleepingsickness/health_professionals/index.html</a>. Last reviewed February 16, 2022. Accessed March 16, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15361733">
<a name="15361733"></a>Faust SN, Woodrow CJ, Patel S, et al. Sleeping sickness in brothers in London. <i>Pediatr Infect Dis J</i>. 2004;23(9):879-881. doi:10.1097/01.inf.0000137587.80399.3b<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/suramin-united-states-available-via-cdc-drug-service-investigational-drug-ind-protocol-only-pediatric-drug-information/abstract-text/15361733/pubmed" id="15361733" target="_blank">15361733</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21628620">
<a name="21628620"></a>Kappagoda S, Singh U, Blackburn BG. Antiparasitic therapy. <i>Mayo Clin Proc</i>. 2011;86(6):561-583. doi:10.4065/mcp.2011.0203<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/suramin-united-states-available-via-cdc-drug-service-investigational-drug-ind-protocol-only-pediatric-drug-information/abstract-text/21628620/pubmed" id="21628620" target="_blank">21628620</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32668640">
<a name="32668640"></a>Vayne C, Guéry EA, Rollin J, Baglo T, Petermann R, Gruel Y. Pathophysiology and diagnosis of drug-induced immune thrombocytopenia. <i>J Clin Med</i>. 2020;9(7):2212. doi:10.3390/jcm9072212<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/suramin-united-states-available-via-cdc-drug-service-investigational-drug-ind-protocol-only-pediatric-drug-information/abstract-text/32668640/pubmed" id="32668640" target="_blank">32668640</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8396782">
<a name="8396782"></a>Voogd TE, Vansterkenburg EL, Wilting J, et al. Recent research on the biological activity of suramin. <i>Pharmacol Rev. </i>1993;45(2):177-203.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/suramin-united-states-available-via-cdc-drug-service-investigational-drug-ind-protocol-only-pediatric-drug-information/abstract-text/8396782/pubmed" id="8396782" target="_blank">8396782</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  “WHO Model Prescribing Information: Drugs Used in Parasitic Diseases,” Geneva: World Health Organization, 1995.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31844000">
<a name="31844000"></a>Wiedemar N, Hauser DA, Mäser P. 100 years of suramin. <i>Antimicrob Agents Chemother.</i> 2020;64(3):e01168-19. doi:10.1128/AAC.01168-19<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/suramin-united-states-available-via-cdc-drug-service-investigational-drug-ind-protocol-only-pediatric-drug-information/abstract-text/31844000/pubmed" id="31844000" target="_blank">31844000</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 132034 Version 11.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
